Template:AHA SAH BP Guidelines: Difference between revisions

Revision as of 22:23, 3 June 2015

No well-controlled studies exist that answer whether BP control influences rebreeding
BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, Level of Evidence B).
Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)

↑ Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 PDF

@@ Line 1: / Line 1: @@
 ===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===
-#To date, no well-controlled studies exist that answer whether blood pressure control in acute Aneurysmal Subarachnoid Hemorrhage influences rebreeding.
+#No well-controlled studies exist that answer whether BP control influences rebreeding
-#Blood pressure should be monitored and controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels|Level of Evidence B]]).
+#BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[EBQ:Evidence_Levels|Level of Evidence B]]).
-#Nicardipine, labetalol, and esmolol are appropriate choices for blood pressure control.  Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided.
+#Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)